Published in Infect Immun on May 01, 1989
In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies. Infect Immun (1992) 3.07
A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis. Infect Immun (1990) 2.55
Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages. Infect Immun (1992) 1.42
Human recombinant tumor necrosis factor alpha protects susceptible A/J mice against lethal Plasmodium chabaudi AS infection. Infect Immun (1989) 1.07
Human rTNF alpha augments anti-bacterial resistance in mice: potentiation of its effects by recombinant human rIL-1 alpha. Immunology (1990) 1.06
Inhibition of infection of macrophages with Ehrlichia risticii by cytochalasins, monodansylcadaverine, and taxol. Infect Immun (1994) 1.05
A tumor necrosis factor mimetic peptide activates a murine macrophage cell line to inhibit mycobacterial growth in a nitric oxide-dependent fashion. Infect Immun (1998) 1.02
Restricted replication of Listeria monocytogenes in a gamma interferon-activated murine hepatocyte line. Infect Immun (1995) 1.02
Use of immune modulators in nonspecific therapy of bacterial infections. Antimicrob Agents Chemother (1992) 0.93
Tumor necrosis factor (TNF) and a TNF-mimetic peptide modulate the granulomatous response to Mycobacterium bovis BCG infection in vivo. Infect Immun (1999) 0.88
Use of recombinant interleukin-2 to enhance adoptive transfer of resistance to Listeria monocytogenes infection. Infect Immun (1992) 0.84
Tumor necrosis factor (TNF). Science (1985) 8.80
Cachectin: more than a tumor necrosis factor. N Engl J Med (1987) 8.74
Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med (1988) 7.96
Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature (1986) 4.06
Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection. Infect Immun (1988) 3.70
Macrophages as a source of tumoricidal activity (tumor-necrotizing factor). Infect Immun (1980) 3.41
Production of tumor necrosis factor during murine listeriosis. J Immunol (1987) 3.14
Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole. J Immunol (1987) 2.91
Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes. J Immunol (1987) 2.08
Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. J Immunol (1987) 1.97
Immunomodulatory properties of recombinant murine and human tumor necrosis factor. Cancer Res (1988) 1.84
Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha. J Immunol (1988) 1.71
Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1. J Immunol (1987) 1.66
Recombinant interleukin-1 alpha and recombinant tumor necrosis factor alpha synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes. Infect Immun (1988) 1.48
Induction of tumor necrosis factor, IFN-gamma, and acute lethality in mice by toxic and non-toxic forms of lipid A. J Immunol (1988) 1.38
Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophils. Blood (1988) 1.32
Human granulocyte-monocyte colony-stimulating factor and interleukin 3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism. Blood (1988) 1.26
Tumor necrosis factor and interleukin-1: role in acute inflammation and microvascular injury. J Lab Clin Med (1987) 1.05
Pharmacokinetics of murine tumor necrosis factor. J Immunopharmacol (1986) 1.02
Tumor necrosis factor and interleukin 1 as mediators of endotoxin-induced beneficial effects. Rev Infect Dis (1988) 0.99
Recombinant tumor necrosis factor can induce interleukin 2 receptor expression and cytolytic activity in a rat x mouse T cell hybrid. Eur J Immunol (1987) 0.96
A sensitive immunochemical assay for biologically active MuIFN-gamma. J Immunol Methods (1987) 2.89
Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med (1996) 2.39
Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol (1999) 2.25
Expression of functional CD40 by vascular endothelial cells. J Exp Med (1995) 2.16
Recombinant human Fas ligand induces alveolar epithelial cell apoptosis and lung injury in rabbits. Am J Physiol Lung Cell Mol Physiol (2001) 2.16
Molecular cloning and structural analysis of murine thymidine kinase genomic and cDNA sequences. Mol Cell Biol (1985) 2.13
Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor. J Virol (1995) 2.05
Reversible inhibitors of penicillinases. Biochem J (1978) 2.00
Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors. Proc Natl Acad Sci U S A (1996) 1.93
Effects of tetracycline on leukotaxis. J Infect Dis (1974) 1.69
Cloning and expression of murine lymphotoxin cDNA. J Immunol (1987) 1.62
In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632. Antimicrob Agents Chemother (2000) 1.59
The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells. J Biol Chem (1996) 1.58
Production of a variant of beta-lactamase II with selectively decreased cephalosporinase activity by a mutant of Bacillus cereus 569/H/9. Biochem J (1980) 1.50
Induction of aryl hydrocarbon hydroxylase in human pulmonary alveolar macrophages by cigarette smoking. J Clin Invest (1973) 1.45
Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab. Curr Top Microbiol Immunol (2008) 1.42
A macrophage receptor for (mannose/glucosamine)-glycoproteins of potential importance in phagocytic activity. Biochem Biophys Res Commun (1980) 1.42
Mechanism of substrate-induced inactivation of beta-lactamase I. Eur J Biochem (1980) 1.39
Induction of tumor necrosis factor, IFN-gamma, and acute lethality in mice by toxic and non-toxic forms of lipid A. J Immunol (1988) 1.38
Initiation of genetic exchanges in lambda phage--prophage crosses. Proc Natl Acad Sci U S A (1977) 1.34
Erythromycin-induced suppression of pulmonary antibacterial defenses. A potential mechanism of superinfection in the lung. Am Rev Respir Dis (1987) 1.32
Substrate-induced deactivation of penicillinases. Studies of beta-lactamase I by hydrogen exchange. Biochem J (1977) 1.32
Activation of human monocytes through CD40 induces matrix metalloproteinases. J Immunol (1996) 1.32
Activation of p34cdc2 coincident with taxol-induced apoptosis. Cell Growth Differ (1994) 1.26
BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agents. Antimicrob Agents Chemother (2000) 1.26
Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines. Cancer Res (1988) 1.25
Genetic exchanges caused by ultraviolet photoproducts in phage lambda DNA molecules: the role of DNA replication. Mol Gen Genet (1976) 1.24
Physical associations between CD45 and CD4 or CD8 occur as late activation events in antigen receptor-stimulated human T cells. J Immunol (1991) 1.22
Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide. Exp Cell Res (1990) 1.22
Normal human bronchial immunoglobulins and proteins: effects of cigarette smoking. Am Rev Respir Dis (1977) 1.21
Partial purification and characterization of the mRNA for human thymidine kinase and hypoxanthine/guanine phosphoribosyltransferase. Proc Natl Acad Sci U S A (1982) 1.19
Pulmonary and systemic defenses against challenge with Staphylococcus aureus in mice with pneumonia due to influenza A virus. J Infect Dis (1979) 1.18
Histochemical staining and in vitro spreading of human pulmonary alveolar macrophages: variability with cigarette smoking status. J Reticuloendothel Soc (1978) 1.17
Genomic cloning and preliminary characterization of the human thymidine kinase gene. Proc Natl Acad Sci U S A (1983) 1.16
In vitro migration of human alveolar macrophages: effects of cigarette smoking. Infect Immun (1973) 1.16
Preliminary crystallographic data for beta-lactamase I from Bacillus cereus 569. J Mol Biol (1978) 1.15
Alveolar macrophage ingestion and phagosome-lysosome fusion defect associated with virus pneumonia. Infect Immun (1980) 1.14
BMS-182123, a fungal metabolite that inhibits the production of TNF-alpha by macrophages and monocytes. J Antibiot (Tokyo) (1996) 1.13
Effects of infection with influenza virus on the function of polymorphonuclear leukocytes. J Infect Dis (1981) 1.10
Stimulation of tyrosine phosphorylation and calcium mobilization by Fc gamma receptor cross-linking. Regulation by the phosphotyrosine phosphatase CD45. J Immunol (1993) 1.10
Transcriptional and posttranscriptional mechanisms regulate murine thymidine kinase gene expression in serum-stimulated cells. Mol Cell Biol (1988) 1.09
Alterations in lung macrophage immune receptor(s) activity associated with viral pneumonia. J Reticuloendothel Soc (1979) 1.06
Ultrastructural alterations in phagocytic functions of alveolar macrophages after parainfluenza virus infection. J Reticuloendothel Soc (1979) 1.06
Classification of bronchial lymphocytes from nonsmokers and smokers. Am Rev Respir Dis (1976) 1.03
Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication. Antimicrob Agents Chemother (1996) 1.03
Molecular cloning, mapping to human chromosome 1 q21-q23, and cell binding characteristics of Spalpha, a new member of the scavenger receptor cysteine-rich (SRCR) family of proteins. J Biol Chem (1997) 1.02
Photoengraving of coverslips and slides to facilitate monitoring of micromanipulated cells or chromosome spreads. Exp Cell Res (1981) 1.01
Alveolitis induced by influenza virus. Am Rev Respir Dis (1983) 1.01
Chemotactic responsiveness of human alveolar macrophages: effects of cigarette smoking. Infect Immun (1974) 1.00
Genetic recombination induced by DNA cross-links in repressed phage lambda. Genetics (1973) 0.99
Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis. Genes Immun (2011) 0.98
Genetic control of cobalamin binding in normal and mutant cells: assignment of the gene for 5-methyltetrahydrofolate:L-homocysteine S-methyltransferase to human chromosome 1. Proc Natl Acad Sci U S A (1979) 0.96
Cross-linking of Fc gamma receptor to surface immunoglobulin on B cells provides an inhibitory signal that closes the plasma membrane calcium channel. J Biol Chem (1994) 0.96
A frequent polymorphism for the cytosolic thymidine kinase gene, TK1, (17q21-q22) detected by the enzyme TaqI. Nucleic Acids Res (1986) 0.94
Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells. J Immunol (2000) 0.94
Enzyme-substrate and enzyme-inhibitor complexes of triose phosphate isomerase studied by 31P nuclear magnetic resonance. Biochem J (1979) 0.93
Alterations in lung macrophage antimicrobial activity associated with viral pneumonia. Infect Immun (1979) 0.93
Immune receptors of human alveolar macrophages: comparison between cigarette smokers and nonsmokers. J Reticuloendothel Soc (1977) 0.93
Characterization of murine lung and peritoneal macrophages. J Reticuloendothel Soc (1980) 0.93
Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death. Atherosclerosis (2000) 0.93
Impairment of polymorphonuclear leukocyte immigration as a mechanism of alcohol-induced suppression of pulmonary antibacterial defenses. Am Rev Respir Dis (1983) 0.93
Studies of the histidine residues of triose phosphate isomerase by proton magnetic resonance and x-ray crystallography. J Mol Biol (1976) 0.92
Response of human pulmonary macrophage to migration inhibition factor. Am Rev Respir Dis (1973) 0.92
Assignment of the murine interferon sensitivity and cytoplasmic superoxide dismutase genes to chromosome 16. Science (1980) 0.91
Aminodiol HIV protease inhibitors. 1. Design, synthesis, and preliminary SAR. J Med Chem (1994) 0.91
Murine DNA repair gene located on chromosome 4. Nature (1981) 0.90
Immune complexes of LDL induce atherogenic responses in human monocytic cells. Arterioscler Thromb Vasc Biol (1995) 0.90
Siamycins I and II, new anti-HIV-1 peptides: II. Sequence analysis and structure determination of siamycin I. J Antibiot (Tokyo) (1995) 0.90
Differential activation of phosphotyrosine protein phosphatase activity in a murine T cell hybridoma by monoclonal antibodies to CD45. J Biol Chem (1992) 0.90
Identification of amino acid residues important for ligand binding to Fas. J Exp Med (1997) 0.89
Immune-enhanced phagocytic dysfunction in pulmonary macrophages infected with parainfluenza 1 (Sendai) virus. Am Rev Respir Dis (1981) 0.89
Alterations of pulmonary defense mechanisms by protein depletion diet. Infect Immun (1981) 0.89
Effects of viral pneumonia on lung macrophage lysosomal enzymes. Infect Immun (1979) 0.89
Molecular dissection of mutations at the heterozygous thymidine kinase locus in mouse lymphoma cells. Proc Natl Acad Sci U S A (1990) 0.88
Effect of interferon-gamma on antigen processing in human monocytes. Eur J Immunol (1994) 0.88
Brain-derived cells contain a specific binding site for Gp120 which is not the CD4 antigen. Brain Res (1991) 0.87
The form of 2-phosphoglycollic acid bound by triosephosphate isomerase. Biochem Biophys Res Commun (1978) 0.86
HLA-DR-triggered inhibition of hemopoiesis involves Fas/Fas ligand interactions and is prevented by c-kit ligand. J Immunol (1997) 0.86
Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell development. Cell Death Differ (2000) 0.86
The participation of antiviral immune mechanisms in alveolar macrophage dysfunction during viral pneumonia. Bull Eur Physiopathol Respir (1983) 0.86
Aminodiol HIV protease inhibitors. Synthesis and structure-activity relationships of P1/P1' compounds: correlation between lipophilicity and cytotoxicity. J Med Chem (1996) 0.86
Oncostatin M up-regulates low density lipoprotein receptors in HepG2 cells by a novel mechanism. J Biol Chem (1991) 0.85
Induction of aryl hydrocarbon hydroxylase in human pulmonary alveolar macrophages and peripheral lymphocytes by cigarette tars. Cancer Lett (1977) 0.85
Agonistic activity of a CD40-specific single-chain Fv constructed from the variable regions of mAb G28-5. Crit Rev Immunol (1997) 0.84
Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies. J Immunol (2001) 0.83
Immunotoxicity of organophosphorus compounds. Modulation of cell-mediated immune responses by inhibition of monocyte accessory functions. Clin Immunol Immunopathol (1988) 0.82
Transforming growth factor-beta 1 induces transforming growth factor-alpha promoter activity and transforming growth factor-alpha secretion in the human colon adenocarcinoma cell line FET. Cancer Res (1993) 0.82
Pulmonary inflammatory responses during viral pneumonia and secondary bacterial infection. Inflammation (1983) 0.80
Prostacyclin agonists reduce early atherosclerosis in hyperlipidemic hamsters. Octimibate and BMY 42393 suppress monocyte chemotaxis, macrophage cholesteryl ester accumulation, scavenger receptor activity, and tumor necrosis factor production. Arterioscler Thromb (1993) 0.80
Macrophage-derived factors increase low density lipoprotein uptake and receptor number in cultured human liver cells. J Lipid Res (1991) 0.80
Niruriside, a new HIV REV/RRE binding inhibitor from Phyllanthus niruri. J Nat Prod (1996) 0.80
Inhibition of HIV-1 protease by a boron-modified polypeptide. Biochem Pharmacol (2000) 0.80
Purification and characterization of a high molecular weight type 1 phosphoprotein phosphatase from the human erythrocyte. J Biol Chem (1987) 0.80
CD95 (Fas)-based, superantigen-dependent, CD4+ T cell-mediated down-regulation of human in vitro immunoglobulin responses. J Immunol (1998) 0.80
Lung defenses against viral and bacterial challenges during immunosuppression with cyclophosphamide in mice. Am Rev Respir Dis (1981) 0.79
Superantigen-driven, CD8+ T cell-mediated down-regulation: CD95 (Fas)-dependent down-regulation of human Ig responses despite CD95-independent killing of activated B cells. J Immunol (1998) 0.79
Promotion of activated human B cell apoptosis and inhibition of Ig production by soluble CD95 ligand: CD95-based downregulation of Ig production need not culminate in activated B cell death. Cell Immunol (2000) 0.79
Modulation of differentiation-related responses in human colon carcinoma cells by protein kinase inhibitor H-7. Anticancer Res (1992) 0.79